Electromed Inc (ELMD) is scheduled to release its Q4 2026 earnings on 25 August 2026. Analysts expect quarterly revenue of $19.33 million and earnings of $0.32 per share. For the full year 2026, revenue is forecast at $73.60 million with earnings of $1.22 per share. These estimates have remained unchanged over the past 90 days. In the previous quarter, Electromed beat revenue expectations by 6.04% and earnings estimates by 44.03%, posting actual revenue of $18.58 million and earnings of $0.35 per share. The stock rose 25.11% following the results. Three analysts have set an average one-year price target of $40.33, suggesting 2.24% upside from the current price of $39.45. However, GuruFocus estimates a fair value of $29.08, implying 26.29% downside. The average brokerage recommendation is "outperform".

Electromed, a Minnesota-based airway clearance technology company, reported record financial results for its fiscal 2026 third quarter ended March 31. Net revenues increased 18.4% to $18.6 million, driven by an 18.6% rise in its core homecare market. Operating income surged 76.0% to a record $3.8 million, representing 20.3% of net revenues. Net income reached $3.0 million, or $0.35 per diluted share, up 58.8% year-over-year. The results marked Electromed's 14th consecutive quarter of year-over-year revenue and profit growth. The company ended the quarter with $17.0 million in cash, $28.3 million in accounts receivable, and no debt. CEO Jim Cunniff cited strategic investments in sales teams and 86% coverage of US lives under contract as positioning the company for continued growth.